US Stock MarketDetailed Quotes

VIRX Viracta Therapeutics

Watchlist
  • 0.700
  • +0.010+1.43%
Close May 31 16:00 ET
  • 0.700
  • 0.0000.00%
Post 16:00 ET
27.49MMarket Cap-569P/E (TTM)

Viracta Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
30.78%-7.85M
-12.51%-39.89M
-26.88%-10.03M
-47.20%-10.54M
11.56%-7.99M
0.20%-11.34M
-88.09%-35.46M
-9.60%-7.9M
5.80%-7.16M
-37.02%-9.03M
Net income from continuing operations
25.13%-9.14M
-3.78%-51.06M
-33.30%-13.77M
28.99%-12.6M
-17.97%-12.48M
-15.77%-12.21M
57.13%-49.2M
9.79%-10.33M
-18.97%-17.74M
-15.40%-10.58M
Depreciation and amortization
-9.84%110K
134.29%492K
115.79%123K
184.44%128K
120.37%119K
125.93%122K
17.98%210K
-3.39%57K
-13.46%45K
5.88%54K
Change In working capital
62.23%-318K
735.36%5.08M
258.63%2.31M
-77.88%679K
735.50%2.94M
68.14%-842K
-63.81%608K
-72.86%643K
96.79%3.07M
-133.07%-462K
-Change in prepaid assets
69.92%-114K
245.28%1.43M
337.36%216K
-67.22%199K
3,132.61%1.4M
73.95%-379K
5.74%-985K
-128.98%-91K
56.44%607K
-106.57%-46K
-Change in payables and accrued expense
-134.88%-1.42M
198.74%3.09M
168.73%1.95M
-84.36%343K
350.81%1.4M
54.48%-605K
-43.52%1.03M
-62.07%726K
113.53%2.19M
-201.83%-557K
-Change in other current assets
759.15%1.22M
-0.18%566K
0.00%142K
-0.70%141K
0.00%141K
0.00%142K
-35.86%567K
0.71%142K
0.00%142K
-3.42%141K
-Change in other current liabilities
---3K
42.86%-4K
97.76%-3K
-103.13%-4K
--3K
--0
-158.33%-7K
---134K
4,166.67%128K
--0
Cash from discontinued investing activities
Operating cash flow
30.78%-7.85M
-12.51%-39.89M
-26.88%-10.03M
-47.20%-10.54M
11.56%-7.99M
0.20%-11.34M
-88.09%-35.46M
-9.60%-7.9M
5.80%-7.16M
-37.02%-9.03M
Investing cash flow
Cash flow from continuing investing activities
293.09%14.19M
127.84%15M
4,666.50%9.27M
117.48%9.1M
347.82%3.98M
-7.35M
-517.86%-53.87M
-968.42%-203K
-1,131.24%-52.06M
-32,020.00%-1.61M
Net PPE purchase and sale
----
-206.67%-138K
--0
5,200.00%51K
----
----
82.14%-45K
--0
99.56%-1K
----
Net investment purchase and sale
293.09%14.19M
128.12%15.14M
4,666.50%9.27M
117.38%9.05M
366.90%4.17M
---7.35M
---53.82M
---203K
---52.06M
---1.56M
Cash from discontinued investing activities
Investing cash flow
293.09%14.19M
127.84%15M
4,666.50%9.27M
117.48%9.1M
347.82%3.98M
---7.35M
-517.86%-53.87M
-968.42%-203K
-1,131.24%-52.06M
-32,020.00%-1.61M
Financing cash flow
Cash flow from continuing financing activities
-41,337.50%-6.6M
-98.06%438K
-98.98%218K
0
750.00%204K
100.00%16K
-63.89%22.54M
10,857.29%21.41M
1,153.41%1.1M
-82.61%24K
Net issuance payments of debt
---6.68M
--0
----
----
----
--0
8,641.03%19.99M
----
----
----
Net common stock issuance
--80K
-87.17%299K
-86.74%172K
--0
--127K
--0
-96.26%2.33M
--1.3M
103,200.00%1.03M
--0
Proceeds from stock option exercised by employees
--0
-38.22%139K
-62.90%46K
--0
220.83%77K
128.57%16K
-33.63%225K
254.29%124K
-19.54%70K
-82.35%24K
Cash from discontinued financing activities
Financing cash flow
-41,337.50%-6.6M
-98.06%438K
-98.98%218K
--0
750.00%204K
100.00%16K
-63.89%22.54M
10,857.29%21.41M
1,153.41%1.1M
-82.61%24K
Net cash flow
Beginning cash position
-66.51%12.32M
-64.49%36.77M
-45.23%12.86M
-82.48%14.29M
-80.37%18.1M
-64.49%36.77M
119.91%103.55M
-78.85%23.47M
-33.52%81.58M
-28.63%92.2M
Current changes in cash
98.63%-255K
63.38%-24.46M
-104.05%-539K
97.53%-1.44M
64.15%-3.81M
-64.46%-18.67M
-218.27%-66.78M
279.04%13.3M
-395.07%-58.11M
-64.33%-10.62M
End cash Position
-33.36%12.06M
-66.51%12.32M
-66.51%12.32M
-45.23%12.86M
-82.48%14.29M
-80.37%18.1M
-64.49%36.77M
-64.49%36.77M
-78.85%23.47M
-33.52%81.58M
Free cash flow
30.78%-7.85M
-12.75%-40.03M
-26.88%-10.03M
-46.47%-10.48M
9.90%-8.18M
0.20%-11.34M
-53.67%-35.5M
-9.31%-7.9M
39.47%-7.16M
-37.59%-9.08M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 30.78%-7.85M-12.51%-39.89M-26.88%-10.03M-47.20%-10.54M11.56%-7.99M0.20%-11.34M-88.09%-35.46M-9.60%-7.9M5.80%-7.16M-37.02%-9.03M
Net income from continuing operations 25.13%-9.14M-3.78%-51.06M-33.30%-13.77M28.99%-12.6M-17.97%-12.48M-15.77%-12.21M57.13%-49.2M9.79%-10.33M-18.97%-17.74M-15.40%-10.58M
Depreciation and amortization -9.84%110K134.29%492K115.79%123K184.44%128K120.37%119K125.93%122K17.98%210K-3.39%57K-13.46%45K5.88%54K
Change In working capital 62.23%-318K735.36%5.08M258.63%2.31M-77.88%679K735.50%2.94M68.14%-842K-63.81%608K-72.86%643K96.79%3.07M-133.07%-462K
-Change in prepaid assets 69.92%-114K245.28%1.43M337.36%216K-67.22%199K3,132.61%1.4M73.95%-379K5.74%-985K-128.98%-91K56.44%607K-106.57%-46K
-Change in payables and accrued expense -134.88%-1.42M198.74%3.09M168.73%1.95M-84.36%343K350.81%1.4M54.48%-605K-43.52%1.03M-62.07%726K113.53%2.19M-201.83%-557K
-Change in other current assets 759.15%1.22M-0.18%566K0.00%142K-0.70%141K0.00%141K0.00%142K-35.86%567K0.71%142K0.00%142K-3.42%141K
-Change in other current liabilities ---3K42.86%-4K97.76%-3K-103.13%-4K--3K--0-158.33%-7K---134K4,166.67%128K--0
Cash from discontinued investing activities
Operating cash flow 30.78%-7.85M-12.51%-39.89M-26.88%-10.03M-47.20%-10.54M11.56%-7.99M0.20%-11.34M-88.09%-35.46M-9.60%-7.9M5.80%-7.16M-37.02%-9.03M
Investing cash flow
Cash flow from continuing investing activities 293.09%14.19M127.84%15M4,666.50%9.27M117.48%9.1M347.82%3.98M-7.35M-517.86%-53.87M-968.42%-203K-1,131.24%-52.06M-32,020.00%-1.61M
Net PPE purchase and sale -----206.67%-138K--05,200.00%51K--------82.14%-45K--099.56%-1K----
Net investment purchase and sale 293.09%14.19M128.12%15.14M4,666.50%9.27M117.38%9.05M366.90%4.17M---7.35M---53.82M---203K---52.06M---1.56M
Cash from discontinued investing activities
Investing cash flow 293.09%14.19M127.84%15M4,666.50%9.27M117.48%9.1M347.82%3.98M---7.35M-517.86%-53.87M-968.42%-203K-1,131.24%-52.06M-32,020.00%-1.61M
Financing cash flow
Cash flow from continuing financing activities -41,337.50%-6.6M-98.06%438K-98.98%218K0750.00%204K100.00%16K-63.89%22.54M10,857.29%21.41M1,153.41%1.1M-82.61%24K
Net issuance payments of debt ---6.68M--0--------------08,641.03%19.99M------------
Net common stock issuance --80K-87.17%299K-86.74%172K--0--127K--0-96.26%2.33M--1.3M103,200.00%1.03M--0
Proceeds from stock option exercised by employees --0-38.22%139K-62.90%46K--0220.83%77K128.57%16K-33.63%225K254.29%124K-19.54%70K-82.35%24K
Cash from discontinued financing activities
Financing cash flow -41,337.50%-6.6M-98.06%438K-98.98%218K--0750.00%204K100.00%16K-63.89%22.54M10,857.29%21.41M1,153.41%1.1M-82.61%24K
Net cash flow
Beginning cash position -66.51%12.32M-64.49%36.77M-45.23%12.86M-82.48%14.29M-80.37%18.1M-64.49%36.77M119.91%103.55M-78.85%23.47M-33.52%81.58M-28.63%92.2M
Current changes in cash 98.63%-255K63.38%-24.46M-104.05%-539K97.53%-1.44M64.15%-3.81M-64.46%-18.67M-218.27%-66.78M279.04%13.3M-395.07%-58.11M-64.33%-10.62M
End cash Position -33.36%12.06M-66.51%12.32M-66.51%12.32M-45.23%12.86M-82.48%14.29M-80.37%18.1M-64.49%36.77M-64.49%36.77M-78.85%23.47M-33.52%81.58M
Free cash flow 30.78%-7.85M-12.75%-40.03M-26.88%-10.03M-46.47%-10.48M9.90%-8.18M0.20%-11.34M-53.67%-35.5M-9.31%-7.9M39.47%-7.16M-37.59%-9.08M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg